Literature DB >> 3034134

Chronic Epstein-Barr virus infection.

J F Jones, S E Straus.   

Abstract

The Epstein-Barr virus (EBV) has been associated with classic infectious mononucleosis, Burkitt's lymphoma, nasopharyngeal carcinoma, and B-cell lymphomas in primary and secondary immunodeficiency disease. The availability of specific serologic diagnosis of EBV, rather than dependence on heterophile antibody positivity, has broadened the scope of EBV-associated diseases. A chronic neuroasthenia syndrome accompanied by antibody titers to the viral capsid antigen and early antigen of EBV, which are higher than found in asymptomatic individuals, is one such additional EBV-associated syndrome. This paper describes the clinical and laboratory responses to EBV that are present in this chronic syndrome. It then discusses management of these patients and the difficulties in establishing a cause-and-effect relationship between EBV and chronic neuroasthenia along with recommendations for future studies.

Entities:  

Mesh:

Year:  1987        PMID: 3034134     DOI: 10.1146/annurev.me.38.020187.001211

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  19 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Antidepressant therapy in the chronic fatigue syndrome.

Authors:  S Lynch; R Seth; S Montgomery
Journal:  Br J Gen Pract       Date:  1991-08       Impact factor: 5.386

3.  Immunologic abnormalities in chronic fatigue syndrome.

Authors:  N G Klimas; F R Salvato; R Morgan; M A Fletcher
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 4.  Fatigue syndrome: neurasthenia revived.

Authors:  P White
Journal:  BMJ       Date:  1989-05-06

Review 5.  Treatment of patients with chronic fatigue syndrome.

Authors:  N M Gantz; G P Holmes
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

6.  Chronic Epstein-Barr virus syndrome.

Authors:  J F Jones
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

Review 7.  [Chronic fatigue syndrome].

Authors:  S Ewig; H J Dengler
Journal:  Klin Wochenschr       Date:  1990-08-17

8.  Primary fibromyalgia and the chronic fatigue syndrome.

Authors:  A J Wysenbeek; Y Shapira; L Leibovici
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

9.  Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection.

Authors:  Masao Hagihara; Takahide Tsuchiya; Osamu Hyodo; Yoko Ueda; Kei Tazume; Aya Masui; Ayako Kanemura; Fumiaki Yoshiba; Shinji Takashimizu; Shohei Matzusaki; Shunichi Kato; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

10.  Childhood adversity and cell-mediated immunity in young adulthood: does type and timing matter?

Authors:  Natalie Slopen; Katie A McLaughlin; Erin C Dunn; Karestan C Koenen
Journal:  Brain Behav Immun       Date:  2012-10-26       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.